Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women

Nutrition Journal

Abdullah H Baqui³  Robert E Black¹  Rubhana Raqib³  Abdullah Al Mahmud³  Daniel E Roth² 

[1] Department of International Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA;Current address: Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada;International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh

关键词: Pharmacokinetics;    Pregnancy;    Bangladesh;    Vitamin D;   

Others  :  823753
DOI  :  10.1186/1475-2891-11-114

 received in 2012-04-10, accepted in 2012-12-21,  发布年份 2012

【 摘 要 】

Background

Improvements in antenatal vitamin D status may have maternal-infant health benefits. To inform the design of prenatal vitamin D3 trials, we conducted a pharmacokinetic study of single-dose vitamin D3 supplementation in women of reproductive age.

Methods

A single oral vitamin D3 dose (70,000 IU) was administered to 34 non-pregnant and 27 pregnant women (27 to 30 weeks gestation) enrolled in Dhaka, Bangladesh (23°N). The primary pharmacokinetic outcome measure was the change in serum 25-hydroxyvitamin D concentration over time, estimated using model-independent pharmacokinetic parameters.

Results

Baseline mean serum 25-hydroxyvitamin D concentration was 54 nmol/L (95% CI 47, 62) in non-pregnant participants and 39 nmol/L (95% CI 34, 45) in pregnant women. Mean peak rise in serum 25-hydroxyvitamin D concentration above baseline was similar in non-pregnant and pregnant women (28 nmol/L and 32 nmol/L, respectively). However, the rate of rise was slightly slower in pregnant women (i.e., lower 25-hydroxyvitamin D on day 2 and higher 25-hydroxyvitamin D on day 21 versus non-pregnant participants). Overall, average 25-hydroxyvitamin D concentration was 19 nmol/L above baseline during the first month. Supplementation did not induce hypercalcemia, and there were no supplement-related adverse events.

Conclusions

The response to a single 70,000 IU dose of vitamin D3 was similar in pregnant and non-pregnant women in Dhaka and consistent with previous studies in non-pregnant adults. These preliminary data support the further investigation of antenatal vitamin D3 regimens involving doses of ≤70,000 IU in regions where maternal-infant vitamin D deficiency is common.

Trial registration

ClinicalTrials.gov (NCT00938600)

【 授权许可】

   
2012 Roth et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Ross AC, Taylor CL, Yaktine AL, Del Valle HB: Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2010.
• [2]ACOG Committee Opinion No. 495: Vitamin D: screening and supplementation during pregnancy. Obstet Gynecol 2011, 118:197-198.
• [3]Specker BL: Does vitamin D during pregnancy impact offspring growth and bone? Proc Nutr Soc 2011, FirstView:1-8.
• [4]Roth DE: Vitamin D, supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials. J Perinatol 2011, 31:449-459.
• [5]Sahu M, Das V, Aggarwal A, Rawat V, Saxena P, Bhatia V: Vitamin D replacement in pregnant women in rural north India: a pilot study. Eur J Clin Nutr 2009, 63:1157-1159.
• [6]Zeghoud F, Garabedian M, Jardel A, Bernard N, Melchior J: Administration of a single dose of 100,000 U.I. of vitamin D3 in the pregnant woman in winter. The effect on blood calcium level of the newborn infant. J Gynecol Obstet Biol Reprod (Paris) 1988, 17:1099-1105.
• [7]Marwahaa RK, Tandona N, Chopraa S, Agarwala NM, Garga K, Sharmaa B, Kanwara RS, Bhadraa K, Singha S, et al.: Vitamin D status in pregnant Indian women across trimesters and different seasons and its correlation with neonatal serum 25-hydroxyvitamin D levels. Br J Nutr 2011, 106:1383-1389.
• [8]Roth DE, Shah MR, Black RE, Baqui AH: Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants. J Health Popul Nutr 2010, 28:458-469.
• [9]Seamans KM, Cashman KD: Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009, 89:1997S-2008S.
• [10]Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
• [11]Ilahi M, Armas LA, Heaney RP: Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008, 87:688-691.
• [12]Maalouf J, Nabulsi M, Vieth R, Kimball S, El-Rassi R, Mahfoud Z, El-Hajj Fuleihan G: Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J Clin Endocrinol Metab 2008, 93:2693-2701.
• [13]Wagner D, Hanwell HE, Vieth R: An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 2009, 42:1549-1556.
• [14]Carter GD, Berry JL, Gunter E, Jones G, Jones JC, Makin HL, Sufi S, Wheeler MJ: Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol 2010, 121:176-179.
• [15]Standing Committee on the Scientific Evaluation of Dietary Reference Intakes: Food and Nutrition Board IOM. In Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington: National Academy Press; 1997.
• [16]Vieth R, Chan PC, MacFarlane GD: Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001, 73:288-294.
• [17]Gordon AY, Salzman P: Optimality of the Holm procedure among general step-down multiple testing procedures. Stat Probability Lett 2008, 78:1878-1884.
• [18]Payne RB, Little AJ, Evans RT: Albumin-adjusted calcium concentration in serum increases during normal pregnancy. Clin Chem 1990, 36:142-144.
• [19]Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E, Carnevale V, Scillitani A, Minisola S: Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008, 93:3015-3020.
• [20]Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V, Mascia ML, Battista C, Viti R, et al.: Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metabol 2010, 95:4771-4777.
• [21]Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR: High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009, 20:1407-1415.
• [22]Weisman Y, Schen RJ, Eisenberg Z, Amarilio N, Graff E, Edelstein-Singer M, Goldray D, Harell A: Single oral high-dose vitamin D3 prophylaxis in the elderly. J Am Geriatr Soc 1986, 34:515-518.
• [23]Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC: Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303:1815-1822.
• [24]Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL: Vitamin D supplementation during pregnancy: Double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011, 26:2341-2357.
• [25]Vähävihu K, Ylianttila L, Kautiainen H, Viljakainen H, Lamberg-Allardt C, Hasan T, Tuohimaa P, Reunala T, Snellman E: Narrowband ultraviolet B course improves vitamin D balance in women in winter. Br J Dermatol 2010, 162:848-853.
• [26]Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P: Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 1981, 67:589-596.
• [27]Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J: Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993, 91:2552-2555.
• [28]Heaney RP: Vitamin D, and calcium interactions: functional outcomes. Am J Clin Nutr 2008, 88:541S-544S.
• [29]Vieth R: How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 2009, 29:3675-3684.